ADVATE: payments to doctors
Payments that named ADVATE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.1M
- Providers
- 565
- Transactions
- 1,927
- Average per transaction
- $566
The per-transaction average — $566 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 565 providers the average total is $1,929, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Shire North American Group Inc | $552,540 | 50.7% |
| Takeda Pharmaceuticals U.S.A., Inc. | $537,245 | 49.3% |